Takeda · 9 hours ago
Head of GI Cancers, Global Marketing, Oncology Business Unit
Boston, MA
Full-time
Onsite
Director/Executive
$208K/yr - $327K/yr
10+ years expTakeda is a company dedicated to curing cancer and is seeking a Head of GI Cancers for their Global Marketing, Oncology Business Unit. The role involves shaping global asset strategy, leading a high-performing team, and driving the development of marketing strategies for GI oncology assets to maximize portfolio value.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Shape and influence global asset strategy through deep collaboration with R&D and Global Product Leaders, driving the development of the Clinical Development Program (CDP) and other critical asset components
Partner with senior leadership across functions, including the Global Product Team—to accelerate asset development and deliver on KPI’s & revenue targets
Lead execution of the global asset strategy, ensuring commercial launch readiness and alignment with Takeda Oncology’s overarching business objectives
Drive development of the GI Disease Area Strategy and Brand Plan, including branding elements, financial planning, forecasting, and life cycle management to maximize portfolio value
Inspire and lead a high-performing team of Global Brand and CDx Leads, fostering strategic excellence and flawless execution to achieve brand success and competitive differentiation
Set the strategic commercial direction for GI oncology asset, driving portfolio optimization through validated growth opportunities, life cycle management (LCM), and prioritized initiatives
Own enterprise-level launch readiness, ensuring governance alignment and flawless execution of pre-launch and launch activities
Lead insight-driven decision-making, converting market intelligence into a compelling brand narrative; leverage analytics to validate opportunities, optimize marketing mix, and maximize ROI on brand investments
Shape managed markets strategy to secure long-term brand value, partnering across internal and external stakeholders to deliver pricing, access, and reimbursement solutions
Drive LCM strategy to expand indications and sustain competitive advantage, proactively anticipating market dynamics and orchestrating cross-functional execution to maximize asset value
Qualification
Required
Bachelor's degree with 10+ years of progressive pharmaceutical experience in marketing, or strategy, including exposure to both U.S. and ex-U.S. markets
Proven oncology expertise, including in new product planning, and successful launch execution
Deep oncology knowledge, market dynamics, brand/franchise management, and effective HCP engagement strategies
3–5+ years of leadership experience, with a track record of managing and developing high-performing teams
Demonstrated P&L ownership and strong financial acumen, including forecasting and resource allocation
Extensive experience in marketing strategy and execution, with the ability to communicate vision and influence internal stakeholders and external agencies
Strong collaboration skills, partnering effectively across countries, functions, and senior leadership to drive asset development and revenue growth
Proven ability to manage complexity and lead through change, demonstrating learning agility and adaptability
Strategic decision-making capability, balancing business, financial, and risk considerations to deliver optimal outcomes
Influential leadership, including situations without direct authority, to align stakeholders and drive results
Preferred
MBA and/or PhD
Experience in GI Cancers
Benefits
Short-term and/ or long-term incentives
Medical, dental, vision insurance
A 401(k) plan and company match
Short-term and long-term disability coverage
Basic life insurance
A tuition reimbursement program
Paid volunteer time off
Company holidays
Well-being benefits
Up to 80 hours of sick time
Up to 120 hours of paid vacation
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
10001+ employees
H1B Sponsorship
Takeda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (39)
2023 (38)
2022 (34)
2021 (44)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Christophe Weber
President and CEO
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
Recent News
2026-01-14
Pharmaceutical Technology
2026-01-11
Company data provided by crunchbase